Collegium Pharmaceutical Inc —— 财务报表 (NASDAQ:COLL) | MetaTrader

展开完整图表

新闻

Collegium Pharmaceutical, Inc. (COLL) Discusses Acquisition of AZSTARYS to Expand ADHD Portfolio and Accelerate Growth - Slideshow (NASDAQ:COLL) 2026-03-24

Collegium Pharmaceuticals: Another M&A Episode Adds To An Intriguing Case (NASDAQ:COLL)

Collegium Pharmaceutical, Inc. (COLL) Discusses Acquisition of AZSTARYS to Expand ADHD Portfolio and Accelerate Growth Transcript

Collegium Pharmaceutical, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:COLL) 2026-03-01

Collegium Pharmaceutical (COLL) Reports Q4 Earnings: What Key Metrics Have to Say

Collegium Pharmaceutical (COLL) Q4 Earnings and Revenues Miss Estimates

Collegium Q4 2025 slides: ADHD drug surges despite earnings miss

Collegium PharmaceuticalQ4每股收益及营收逊于预期

Collegium Pharmaceutical earnings missed by $0.10, revenue fell short of estimates

Collegium Pharmaceutical财报前瞻:Jornay PM成关注焦点

Collegium Pharmaceutical earnings ahead: Jornay PM in focus

Rigel Pharmaceuticals (RIGL) Earnings Expected to Grow: Should You Buy?